Pacific Global Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $210K | Sell |
255
-125
| -33% | -$104K | 0.3% | 64 |
|
|
2024
Q4 | $293K | Sell |
380
-6,517
| -94% | -$5.4M | 0.38% | 59 |
|
|
2024
Q3 | $6.11M | Sell |
6,897
-278
| -4% | -$250K | 1.1% | 24 |
|
|
2024
Q2 | $6.5M | Sell |
7,175
-138
| -2% | -$110K | 1.23% | 19 |
|
|
2024
Q1 | $5.69M | Sell |
7,313
-34
| -0.5% | -$24.2K | 1.09% | 24 |
|
|
2023
Q4 | $4.28M | Sell |
7,347
-336
| -4% | -$196K | 0.87% | 30 |
|
|
2023
Q3 | $4.13M | Sell |
7,683
-300
| -4% | -$155K | 0.91% | 33 |
|
|
2023
Q2 | $3.74M | Sell |
7,983
-59
| -0.7% | -$24.7K | 0.77% | 34 |
|
|
2023
Q1 | $2.76M | Sell |
8,042
-397
| -5% | -$134K | 0.6% | 43 |
|
|
2022
Q4 | $3.09M | Sell |
8,439
-25
| -0.3% | -$8.86K | 0.68% | 37 |
|
|
2022
Q3 | $2.74M | Buy |
8,464
+43
| +0.5% | +$13.6K | 0.66% | 37 |
|
|
2022
Q2 | $2.73M | Sell |
8,421
-270
| -3% | -$81K | 0.64% | 43 |
|
|
2022
Q1 | $2.49M | Sell |
8,691
-187
| -2% | -$48.1K | 0.49% | 53 |
|
|
2021
Q4 | $2.45M | Sell |
8,878
-155
| -2% | -$39.3K | 0.45% | 54 |
|
|
2021
Q3 | $2.09M | Buy |
9,033
+212
| +2% | +$52.3K | 0.42% | 55 |
|
|
2021
Q2 | $2.02M | Sell |
8,821
-331
| -4% | -$66.5K | 0.4% | 62 |
|
|
2021
Q1 | $1.71M | Buy |
9,152
+2,683
| +41% | +$525K | 0.36% | 70 |
|
|
2020
Q4 | $1.09M | Buy |
6,469
+342
| +6% | +$51.1K | 0.24% | 88 |
|
|
2020
Q3 | $907K | Sell |
6,127
-385
| -6% | -$59.6K | 0.24% | 89 |
|
|
2020
Q2 | $1.07M | Sell |
6,512
-689
| -10% | -$106K | 0.3% | 76 |
|
|
2020
Q1 | $999K | Sell |
7,201
-446
| -6% | -$61.3K | 0.32% | 82 |
|
|
2019
Q4 | $1M | Sell |
7,647
-2
| -0% | -$232 | 0.22% | 105 |
|
|
2019
Q3 | $855K | Sell |
7,649
-77
| -1% | -$8.57K | 0.2% | 112 |
|
|
2019
Q2 | $856K | Sell |
7,726
-108
| -1% | -$12.7K | 0.2% | 114 |
|
|
2019
Q1 | $1.02M | Sell |
7,834
-194
| -2% | -$23.6K | 0.22% | 104 |
|
|
2018
Q4 | $929K | Buy |
8,028
+250
| +3% | +$27.9K | 0.23% | 105 |
|
|
2018
Q3 | $835K | Sell |
7,778
-36
| -0.5% | -$3.6K | 0.17% | 120 |
|
|
2018
Q2 | $667K | Sell |
7,814
-23
| -0.3% | -$1.89K | 0.15% | 135 |
|
|
2018
Q1 | $606K | Buy |
7,837
+7
| +0.1% | +$564 | 0.14% | 144 |
|
|
2017
Q4 | $661K | Buy |
7,830
+11
| +0.1% | +$936 | 0.14% | 139 |
|
|
2017
Q3 | $669K | Sell |
7,819
-409
| -5% | -$33.5K | 0.15% | 137 |
|
|
2017
Q2 | $677K | Sell |
8,228
-224
| -3% | -$18.3K | 0.16% | 136 |
|
|
2017
Q1 | $711K | Sell |
8,452
-30
| -0.4% | -$2.4K | 0.14% | 137 |
|
|
2016
Q4 | $624K | Sell |
8,482
-30
| -0.4% | -$2.23K | 0.13% | 144 |
|
|
2016
Q3 | $683K | Sell |
8,512
-95
| -1% | -$7.6K | 0.15% | 135 |
|
|
2016
Q2 | $678K | Sell |
8,607
-201
| -2% | -$15.1K | 0.16% | 133 |
|
|
2016
Q1 | $634K | Sell |
8,808
-463
| -5% | -$35K | 0.14% | 136 |
|
|
2015
Q4 | $781K | Sell |
9,271
-389
| -4% | -$32.3K | 0.18% | 130 |
|
|
2015
Q3 | $808K | Sell |
9,660
-616
| -6% | -$52K | 0.18% | 126 |
|
|
2015
Q2 | $858K | Sell |
10,276
-1,689
| -14% | -$129K | 0.16% | 126 |
|
|
2015
Q1 | $869K | Sell |
11,965
-27
| -0.2% | -$1.92K | 0.16% | 127 |
|
|
2014
Q4 | $827K | Buy |
11,992
+12
| +0.1% | +$810 | 0.15% | 128 |
|
|
2014
Q3 | $777K | Sell |
11,980
-2,061
| -15% | -$130K | 0.13% | 130 |
|
|
2014
Q2 | $873K | Sell |
14,041
-247
| -2% | -$14.7K | 0.13% | 130 |
|
|
2014
Q1 | $841K | Buy |
14,288
+530
| +4% | +$29.6K | 0.13% | 129 |
|
|
2013
Q4 | $702K | Buy |
13,758
+20
| +0.1% | +$1K | 0.12% | 135 |
|
|
2013
Q3 | $691K | Sell |
13,738
-47
| -0.3% | -$2.46K | 0.13% | 133 |
|
|
2013
Q2 | $677K | Buy |
+13,785
| New | +$750K | 0.13% | 122 |
|
Other funds holding LLY
Pacific Global Investment Management's LLY Position: Q1 2025 in Review
Pacific Global Investment Management reduced its Eli Lilly (LLY) stake by 33% in Q1 2025, selling an estimated $104K and leaving 255 shares worth $210K. The position accounts for 0.3% of the portfolio, ranked #64.
Pacific Global Investment Management first reported a position in LLY in Q2 2013 and has held it in 48 quarters since. The position peaked at $6.5M in Q2 2024. 3,919 funds tracked by Wall St. Rank hold LLY as of Q1 2025.
- Pacific Global Investment Management held 255 shares of Eli Lilly worth $210K as of Q1 2025.
- Pacific Global Investment Management sold 125 Eli Lilly shares in Q1 2025, an estimated $104K.
- Eli Lilly made up 0.3% of Pacific Global Investment Management's portfolio in Q1 2025, its #64 holding.
- Pacific Global Investment Management first reported a position in Eli Lilly in Q2 2013 and has held it in 48 quarters since.
- Pacific Global Investment Management's Eli Lilly position peaked at $6.5M in Q2 2024.
- 3,919 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.
Based on Pacific Global Investment Management's 13F filing for Q1 2025, filed 24 Apr 2025.